Background-aim: Diabetes mellitus is one of the most prevalent diseases worldwide. According to the ADA 2020 guidelines, individuals with unstable glycemic control should be monitored every three months by measuring glycated hemoglobin (HbA1c). The aim of this study was to evaluate the demand adequacy for HbA1c in the monitoring of patients with diabetes mellitus with a highly unstable glycemic control.

Methods: Retrospective observational study (2016-2019). All HbA1c tests from individuals ≥18 years requested by hospital physicians were considered.Highly unstable glycemic control was defined as HbA1c≥10.0%, and their monitoring was classified as: (if>3months) and if no further HbA1c measurement was performed by the laboratory.For individuals classified as , medical records were reviewed and further re-classified as: [1] due to patient's responsibility, [2] attributable to the requesting physician, [3] monitored by POCT, [4] unfeasibility of monitoring or [5] referral outside our area for follow-up.

Results: During the assessed period, 1,156 patients had an HbA1c value≥10.0%. 67.5% of them were monitored either in the clinical laboratory or as POCT (33.7% optimal monitoring), whereas 21.0% patients were not monitored due to preventable situations.

Conclusion: Lack of monitoring due to physician's reasons or patient's responsibility highlights the urgent need for an improvement.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941057PMC

Publication Analysis

Top Keywords

unstable glycemic
12
diabetes mellitus
8
glycemic control
8
patient's responsibility
8
monitoring
6
hba1c
5
monitoring diabetic
4
patients
4
diabetic patients
4
patients poor
4

Similar Publications

Background: Intraportal pancreatic islet transplantation is a treatment option for patients with severe beta cell failure and unstable glycemic control. However, this procedure is associated with loss of beta cells after intrahepatic transplantation. Islet delivery devices (IDDs) implanted at extrahepatic sites may support engraftment and improve survival of pancreatic islets.

View Article and Find Full Text PDF

Different levels of lipids, Hb1Ac and cytokines among patients with coronary artery disease.

Heliyon

November 2024

Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, No. 1 Dongjiaomin Lane, Dongcheng District, Beijing, 100730, PR China.

Article Synopsis
  • The study investigates the relationship between lipid levels, glucose levels, and inflammation (cytokines) in patients with various types of coronary artery disease (CAD).
  • Data were collected from 2,147 patients diagnosed with different CAD stages, analyzing factors like IL-6, INF-γ, and Hb1Ac levels across groups such as stable angina, unstable angina, NSTEMI, and STEMI.
  • Results show that acute myocardial infarction patients have significantly higher IL-6 levels and varying lipid and glucose profiles compared to other CAD groups, suggesting that inflammation and metabolic factors may play critical roles in coronary heart disease progression.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the link between high HbA1c levels and the severity of coronary artery disease (CAD) in patients diagnosed with acute coronary syndrome (ACS).
  • It involved 120 patients with different types of ACS who were also diagnosed with diabetes, measuring their HbA1c levels and performing coronary angiography to assess CAD severity.
  • Results showed that higher HbA1c levels (especially above 10.5%) were associated with more severe forms of CAD, suggesting the need for optimal glycemic control to reduce cardiovascular risks.
View Article and Find Full Text PDF
Article Synopsis
  • - The study aims to determine if adding lifestyle education to a physical exercise program improves various health outcomes for individuals with prediabetes or diabetes compared to exercise alone, focusing on areas like functional capacity, disease knowledge, and quality of life.
  • - It is a multicenter, double-blinded, randomized controlled trial lasting 12 weeks, followed by a 6-month assessment, involving adults who meet specific health criteria and are recruited from two Brazilian cities.
  • - Outcomes being measured include improvements in health behaviors, cardiometabolic health parameters, depression, and diet quality, alongside the primary outcomes of functional capacity and disease-related knowledge.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to create and validate models that predict risks related to glucose levels (like high and low sugar levels) using continuous glucose monitoring (CGM) data to help patients and healthcare providers take preventive measures.
  • Researchers analyzed data from 187 type 1 diabetes patients and developed three different prediction models, with XGBoost performing the best in accurately predicting hyperglycemia, hypoglycemia, and glycemic variability.
  • The results showed that these models are effective in predicting risks for unstable glycemic control, demonstrating strong performance in both the original group and in external tests with additional patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!